Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Bacterium or component thereof or substance produced by said...
Reexamination Certificate
2007-05-02
2009-10-20
Mondesi, Robert B (Department: 1645)
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Bacterium or component thereof or substance produced by said...
C424S249100, C424S184100, C530S300000, C530S350000, C435S069100, C435S069700, C536S023100, C536S023700
Reexamination Certificate
active
07604810
ABSTRACT:
To ensure maximum cross-strain recognition and reactivity, regions of proteins that are conserved between different Neisserial species, serogroups and strains can be used. The invention provides proteins which comprise stretches of amino acid sequence that are shared across the majority ofNeisseria, particularlyN. meningitidisandN. gonorrhoeae.
REFERENCES:
patent: 4239749 (1980-12-01), Buchanan
patent: 5547670 (1996-08-01), Goldstein et al.
patent: 6013267 (2000-01-01), Blake et al.
patent: 6028049 (2000-02-01), Jacobs et al.
patent: 6197312 (2001-03-01), Peak et al.
patent: 6248329 (2001-06-01), Chandrashekar et al.
patent: 6709660 (2004-03-01), Scarlato et al.
patent: 6914131 (2005-07-01), Scarlato et al.
patent: 7368261 (2008-05-01), Rappuoli et al.
patent: 2002/0160016 (2002-10-01), Peak et al.
patent: 2004/0092711 (2004-05-01), Arico et al.
patent: 2004/0110670 (2004-06-01), Arico et al.
patent: 2005/0222385 (2005-10-01), Pizza
patent: 2006/0051840 (2006-03-01), Arico et al.
patent: 2006/0171957 (2006-08-01), Pizza
patent: 2007/0082014 (2007-04-01), Costantino
patent: 2008/0241180 (2008-10-01), Contorni
patent: 0273116 (1988-07-01), None
patent: 1790660 (2007-05-01), None
patent: 2720408 (1995-12-01), None
patent: 2003525050 (2003-08-01), None
patent: 8901612 (1990-07-01), None
patent: WO-9006696 (1990-06-01), None
patent: WO-9216643 (1992-10-01), None
patent: WO-9503413 (1995-02-01), None
patent: WO-9533049 (1995-12-01), None
patent: WO-96/29412 (1996-09-01), None
patent: WO-9710844 (1997-03-01), None
patent: WO-9713860 (1997-04-01), None
patent: WO-9728273 (1997-08-01), None
patent: WO-99/24578 (1999-05-01), None
patent: WO-99/36544 (1999-07-01), None
patent: WO-99/57280 (1999-11-01), None
patent: WO-00/22430 (2000-04-01), None
patent: WO-0050075 (2000-08-01), None
patent: WO-0066791 (2000-11-01), None
patent: WO-0071574 (2000-11-01), None
patent: WO-0131019 (2001-05-01), None
patent: WO-0164920 (2001-09-01), None
patent: WO-0164922 (2001-09-01), None
patent: WO-03010194 (2003-02-01), None
patent: WO-03020756 (2003-03-01), None
patent: WO-2004032958 (2004-04-01), None
patent: WO-2004048404 (2004-06-01), None
patent: WO-2004067030 (2004-08-01), None
patent: WO-2004112832 (2004-12-01), None
patent: WO-2005032583 (2005-04-01), None
patent: WO-2005033148 (2005-04-01), None
patent: WO-2005102384 (2005-11-01), None
patent: WO-2005106009 (2005-11-01), None
patent: WO-2008001224 (2008-01-01), None
Bartsevich , vol. 272, No. 10, Issue of Mar. 7, 1997 pp. 6382-6387.
Pizza et al Science 287:1816-1820(2000).
Tettelin et al Science. Mar. 10, 2000; 287(5459):1809-15.
Ala'Aldeen et al. (1996). “The Meningococcal Transferrin-binding Proteins 1 and 2 are Both Surface Exposed and Generate Bactericidal Antibodies Capable of Killing Homologous and Heterologous Strains,”Vaccine14(1):49-53.
Bygraves et al. (1992). “Analysis of the Clonal Relationships Between Strains of Neisseria Meningitidis by Pulsed Field Gel Electrophoresis,”Journal of General Microbiology138:523- 531.
Caugant et al. (1987). “Genetic Structure of Neisseria Meningitidis Populations in Relation to Serogroup, Serotype, and Outer Membrane Protein Pattern,”Journal of Bacteriology69:2781-2792.
Cooney et al. (1993). “Three Contiguous Lipoprotein Genes in Pasteurella haemolytica Al which are Homologous to a Lipoprotein Gene in Haemophilus Influenza Type B,”Infection and Immunity61(11):4682-4688.
Dempsey et al. (1991). “Physical Map of the Chromosome of Neisseria gonorrhoeae FA1090 with Locations of Genetic Markers, including Opa and Pil Genes,”Journal of Bacteriology173:5476-5486.
Devries et al. (Aug. 1996). “Invasion of Primary Nasopharyngeal Epithelial Cells by Neisseria meningitidis is Controlled by Phase Variation of Multiple Surface Antigens,”Infection and Immunity64(8):2998-3006.
Gervais et al. (1992). “Putative Lipoprotein Yaec Precursor,” Database Swissport Acc No. p28635.
Maiden et al. (1998). “Multilocus Sequence Typing:a Portable Approach to the Identification of Clones within Populations of Pathogenic Microorganisms,”Proceedings of the National Academy of Sciences USA95:3140-3145.
Ni et al. (1992). “Phylogenetic and Epidemiological Analysis of Neisseria meningitidis Using DNA Probes,”Epidemiology and Infection109:227-239.
Pettersson et al. (1999). “Sequence Variability of the Meningococcal Lactoferrin-binding Protein LbpB,”Gene231:105-110.
Poolman. (1995). “Development of a Meningococcal Vaccine,”Infectious Agents and Disease4:13-28.
Seiler et al. (1996). “Allelic Polymorphism and Site-specific Recombination in the Opc Locus of Neisseria meningitidis,”Molecular Microbiology19(4):841-856.
Tettelin et al. (2000). “Complete Genome Sequence of Neisseria meningitidis Serogroup B Strain MC58,”Science287:1809-1815.
Thompson et al. (1994). “Clustal W: Improving the Sensitivity of Progressive Multiple Sequence Alignment through Sequence Wighting, Position-specific Gap Penalties and Weight Matrix Choice,”Nucleic Acids Research22:4673-4680.
Thompson et al. (1998). “Multiple Sequence Alignment with Clustal X,”Trends in Biochemical Sciences23:403-405.
Virji et al. (1992). “Variations in the Expression of Pili:the Effect on Adherence of Neisseria meningitidis to Human Epithelial and Endothelial Cells,”Molecular Microbiology6:1271-1279.
Wolff et al. (1992). “Phylogeny and Nucleotide Sequence of a 23S rRNA Gene from Neisseria gonorrhea and Neisseria meningitidis,”Nucleic Acids Research20:4657.
Abad et al. (2008). “PorB2/3 Protein Hybrid in Neisseria meningitidis,” Emerging Infectious Diseases, 14(4):688-689.
Bethell et al. (2002). “Meningococcal vaccines,” Expert Review of Vaccines 1(1):75-84.
Blythe et al. (2005). “Benchmarking B cell epitope prediction: underperformance of existing methods,” Protein Sci. 14:246-248.
Boslego et al. (1991). “Gonorrhea Vaccines” Chapter 17 in Vaccines and Immunotherapy, S. Cryz (Ed.). pp. 211-223.
Bowie, J. et al. (1990). “Deciphering the Message in Protein Sequences: Tolerance to Amino Acid Substitutions,” Science 247: 1306-1310.
Cann et al. (1989). “Detection of Antibodies to Common Antigens of Pathogenic and Commensal Neisseria Species,” Journal of Medical Microbiology 30:23-30.
Christodoulides et al. (1994). “Immunization with a Multiple Antigen Peptide Containing Defined B- and T-Cell Epitopes: Production of Bacterial Antibodies Group B Neisseria Meningitidis,” Microbiology 140:2951-2960.
Cruse et al. Illustrated Dict. Of Immunology, 2nd ed., CRC Press, 2003. pp. 46, 166, and 382.
Ellis (1988). “New Technologies for Making Vaccines” in Vaccines. Plotkin et al. (Eds.) pp. 568-575.
Feng et al. (1996). “P55, an Immunogenic but Nonprotective 55-Kilodalton Borrelia burgdorferi Protein in Murine Lyme Disease,” Infection and Immunity. 64(1):363-365.
Greenspan et al. (1999). “Defining Epitopes: It's Not as Easy as It Seems,” Nature Biotechnology 7:936-937.
Grifantini, R. et al. (2002). “Previously Unrecognized Vaccine Candidates against Group B Meningococcus Identified by DNA Microarrays,” Nature Biotechnology 20(9): 914-921.
Guillen et al. (1996). “Expression inEscherichia coliand Immunological Characterization of a Hybrid Class I-P64K Protein from Neisseria Meningitidis,” Biotecnologia Aplicada13(4):271-275.
Herbert et al. (1995). The Dictionary of Immunology. Academic Press: London 4thedition, 3 pages.
Herbert, W. et al. (1985). The Dictionary of Immunology. Academic Press: London 3rdedition, pp. 58-59.
Holmes, E. (2001). “PSMA Specific Antibodies and their Diagnostic and Therapeutic Use,” Expert Opinion on Investigational Drugs 10(3): 511-519.
Jacobsson et al. (2009). Vaccine. 27:1579-1584.
Jolley et al. (2007). “Molecular typing of meningococci: recommendations for target choice
Baskar Padma V
Gorman Robert
Hessler Amy
Lee Helen
Mondesi Robert B
LandOfFree
Conserved Neisserial antigens does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Conserved Neisserial antigens, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Conserved Neisserial antigens will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4072807